Search for Clinical Trial Results

Sponsored By

Hemorrhagic Fever with Renal Syndrome - 6 Studies Found

Status Study
Enrolling by invitation Study Name: Ribavirin for Hemorrhagic Fever With Renal Syndrome
Condition: Hemorrhagic Fever With Renal Syndrome
Date: 2008-02-13
Interventions: Drug: Ribavirin 7 Day multiple dosing regime based on weight and dosage day
Withdrawn Study Name: Ribavirin for Hemorrhagic Fever With Renal Syndrome in Germany
Condition: Hemorrhagic Fever With Renal Syndrome
Date: 2009-03-24
Interventions: Drug: Virazole (Ribavirin) Duration of Subject Participati
Active, not recruiting Study Name: Phase 2a Immunogenicity Study of Hantaan/Puumala Virus DNA Vaccine for Prevention of Hemorrhagic Fever
Condition: Hemorrhagic Fever With Renal Syndrome
Date: 2014-04-14
Interventions:
  • Biological: HTNV/PUUV DNA vaccine

Completed Study Name: Study to Evaluate the Safety, Tolerability, and Immunogenicity of Hantaan and Puumala Virus DNA Vaccines
Condition: Hemorrhagic Fever With Renal Syndrome
Date: 2011-12-23
Interventions: Biological: Vaccine/device combination for prevention of HFRS PUUV DNA Vaccine, 2.0mg/ml TDS-IM injectio
Recruiting Study Name: Diagnostic of Puumala Virus Infection in France
Condition:
  • Nephropathia Epidemica
  • Hemorrhagic Fever With Renal Syndrome Date: 2015-04-21
Completed Study Name: Study to Evalutate Long-term Immunity of Hantavax in High Risk Population of HFRS
Condition: Infection
Date: 2015-02-03
Interventions: Drug: Hantavax injection Intramuscular or hypodermic injection of 0.5ml per time twice at interval of 1